Fairfax Financial Holdings Limited

Fairfax reported second-quarter 2026 net earnings of $1.4 billion and first-half net earnings of $2.1 billion. Operating income from insurance and reinsurance, adjusted to an undiscounted basis and before risk margin, was $1.1 billion. Underwriting income was $459 million versus $427 million a year ago, and the combined ratio was 93.1% versus 93.3% in Q2 2025. Interest and dividend income was $737 million, up 11% year over year from $660 million, while profits of associates were $43 million versus $131 million a year ago. Net investment gains were $769 million, and book value per share ended at $1,304, up 4.8% from year-end 2025 adjusted for the $15 dividend. Gross premium written was $9.4 billion, up 4.1% year over year. For the quarter, management did not provide formal numerical EPS or full-year earnings guidance, but it reiterated that it has previously referenced about $1 billion of income from associates and consolidated investments combined, and said current results are running above that level.

Peter Clarke emphasized that Fairfax had another strong quarter and pointed to broad-based strength in underwriting, investment income, and capital returns. He said the company remains disciplined in a softer market, especially in North America, and continues to prioritize profitability over top-line growth. He also highlighted a series of strategic moves, including the Poseidon sale, the Kennedy-Wilson privatization, the planned Andrew Peller transaction, and Sleep Country’s acquisition of Sleep Number.

Amy Sherk focused on transaction accounting, balance sheet strength, and capital structure. She said the company held $2.3 billion of cash and investments at the holding company, had an undrawn $2 billion revolving credit facility, and had $4.4 billion of pretax excess fair value over carrying value in noninsurance associates and market-traded consolidated investments. She also noted total debt to total capital, excluding noninsurance companies, increased to 28% from 26.2% at year-end 2025, while book value per basic share was $1,304.39 versus $1,260.19 at December 31, 2025.

Analysts pressed management on whether softening was spreading beyond property into casualty lines; Peter Clarke said pricing pressure is still mainly in property, though casualty may also soften, and that Fairfax is pulling back from less attractive business. Questions on the Fairfax stock TRS and buybacks drew a response that the position has been a strong long-term investment, Fairfax still repurchased nearly 1 million shares, and the stock remains viewed as undervalued. Management also addressed leverage and float, saying float is a long-term focus, underwriting remained profitable, and recent debt issuance largely replaced preferred shares with 30-year debt on better terms.